← Open Payments lookup

APRIL WISEMAN: Open Payments

NPI 1205470747 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,524 in 63 payments from 16 companies in 2025. Trend: 2023 $1,324 · 2024 $1,682 · 2025 $1,524

Food & beverage: $1,329Education: $195
CompanyPaymentsAmount
GENZYME CORPORATION12$304
SUN PHARMACEUTICAL INDUSTRIES INC.7$228
ABBVIE INC.12$216
Janssen Biotech, Inc.5$196
Novartis Pharmaceuticals Corporation4$100
LEO Pharma Inc.4$99
Regeneron Healthcare Solutions, Inc.3$78
Incyte Corporation3$72
Amgen Inc.2$42
PFIZER INC.2$35

Products named: DUPIXENT, SKYRIZI, TREMFYA, ILUMYA, ADBRY, OPZELURA, LIBTAYO, Rhapsido.

Industry payments across TX — which companies pay providers there.